hispolon and Neurodegenerative-Diseases

hispolon has been researched along with Neurodegenerative-Diseases* in 1 studies

Other Studies

1 other study(ies) available for hispolon and Neurodegenerative-Diseases

ArticleYear
Hispolon alleviates oxidative damage by stimulating the Nrf2 signaling pathway in PC12 cells.
    Archives of biochemistry and biophysics, 2022, 09-30, Volume: 727

    Natural products derived from the daily diet are garnering increasing attention for neurodegenerative disease (ND) treatment. Hispolon (His), a small molecule from Phellinus linteus, has been reported to have various pharmacological activities. Here, we evaluated its protective effect on a neuron-like rat pheochromocytoma cell line (PC12). Results showed that His could restore cell death induced by oxidative damage. Nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2) plays a significant role in maintaining cellular redox homeostasis. After treatment with His, some Nrf2-governed antioxidant genes were upregulated in a dose-dependent manner. However, the protective effect of His on PC12 cells was easily terminated by Nrf2 knockdown, demonstrating that Nrf2 is a critical component in this cytoprotective process. Taken together, our study showed that His was not only an effective activator of Nrf2 but also a promising candidate for ND treatment.

    Topics: Animals; Catechols; Neurodegenerative Diseases; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Rats; Signal Transduction

2022